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Isolated endobronchial secondaries are reported usually as single cases or in series from either specialist surgical or 
cancer units. The latter two are selected populations and are not a good guide to the true frequency of occurrence 
of such isolated endobronchial secondaries. The incidence of such endobronchial secondaries in a 15 yr prospective 
series is reported. Results of all fibre-optic bronchoscopies carried out in the Blackburn, Hyndburn and Ribble 
Valley districts from 1981 to 1995 together with histology were recorded prospectively throughout the period. These 
had been audited yearly throughout, the data were collated, and the individual records of cases of endobronchial 
secondaries examined. 
A total of 3353 bronchoscopies were carried out in the years 1981-1995 inclusive. Of these, 1391 had visible 
endobronchial abnormalities, from which 1059 had positive endobronchial histology. Sixteen of the 1059 (1.5%) 
were with endobronchial secondaries. Over the same period eight bronchial carcinoids (none biopsied, but later 
surgically resected) were encountered. Isolated endobronchial secondaries made up a higher proportion of 
endobronchial histology than expected at 1.5% and were twice as frequently found as bronchial carcinoids. The 
possibility of endobronchial secondaries should always be considered in those with a history of previous carcinomas 
at other sites. 
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Introduction 
Extrathoracic malignancies frequently metastasize to the 
lung, pleura and mediastinal lymph nodes. The trachea and 
bronchi are, however, much rarer sites for metastases (1). 
Those cases reported of endobronchial metastasis are 
usually either in the form of single case reports (2,3) or in 
series from hospitals or units with specialist cancer or 
thoracic surgical interest (4-6). One hundred and nineteen 
cases of breast cancer, from a total of 660 followed up, 
developed intrathoracic recurrence of which seven were 
endobronchial (4), and in another series of breast carci- 
noma patients ten cases of endobronchial disease were 
found in 1200 bronchoscopies (5). Twenty-five of 90 
patients seen in a regional thoracic surgical centre 
with pulmonary metastatic disease in a 10 yr series had 
endobronchial metastasis (6). These specialist series may 
overrepresent the true incidence of endobronchial meta- 
stasis because of prior selection. To determine the likely 
true incidence of apparently isolated endobronchial 
metastases, an unselective series of bronchoscopies is 
required. 
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Methods 
All fibre-optic bronchoscopies carried out in the Blackburn, 
Hyndburn and Ribble Valley district from 1981 to 1995 
inclusive have been performed by the three authors. Results 
of the bronchoscopies together with histology were 
recorded prospectively throughout the period and have 
been audited yearly throughout. The yearly data were 
collated, and the individual records of cases of endo- 
bronchial metastases examined, to confirm the diagnosis 
and to determine the latent interval between the primary 
diagnosis and presentation and the survival after the 
diagnosis of endobronchial metastasis. 
Results 
A total of 3353 fibre-optic bronchoscopies were carried out 
in the years 1981-1995 inclusive, of which 1391 had visible 
endobronchial abnormalities, from which 1059 had positive 
endobronchial histology. In all cases the histopathologist 
had been able to compare the endobronchial histology with 
the original histology. Sixteen (1.5%) of the 1059 with 
positive histology had endobronchial metastases (Table 1). 
The latent interval between the diagnosis of the primary 
tumour and the metastasis and that between the diagnosis 
of endobronchial metastasis and death are also given. Over 
the same period eight endobronchial carcinoids (none 
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TABLE 1. Summary of results 
Age Site of 
(years) primary 
Latent interval 
from primary 
diagnosis 
(years) 
Survival 
Post-diagnosis 
of endobronchial 
secondary 
(months) 
Clinical 
and/or X-ray 
features 
55 Breast 13 
59 Breast 12 
64 Breast 9 
59 Breast 5 
34 Breast 6 
69 Breast 8 
57 Breast 9 
69 Colon Concurrent 
72. Colon 8 
84‘ Colon 0.25 
66 Colon 8 
76 Colon 3 
62 Rectum 3 
42 Melanoma 7 
66 Fibrous histiocytoma 2 
67 Transitional cell, bladder Concurrent 
96 
4 
117 
6 
8 
3 
7 
12 
9 
8 
5 
15 
60 
(left pneumonectomy) 
3 
4 
27 
Collapsed right lung 
Stridor, clear X-ray 
Collapsed right lower lobe 
Stridor, clear X-ray 
Stridor, hilar mass 
Dyspnoea; clear X-ray 
Haemoptysis, clear X-ray 
X-ray mass 
Haemoptysis 
X-ray mass 
Collapsed left lower lobe 
Haemoptysis 
Haemoptysis 
Haemoptysis 
Haemoptysis 
Haemoptysis 
biopsied) were encountered. All were subsequently resected 
and confirmed histologically. 
Discussion 
In this unselected series of bronchoscopies, endobronchial 
metastases at 1.5% of positive endobronchial histology were 
found twice as frequently as carcinoid tumours. Although 
these were apparently clinically isolated metastases, the 
short survival time of most of the patients showed that 
this diagnosis was usually the first presentation of more 
disseminated disease which rapidly became apparent on 
investigation including scanning. Three patients, however, 
had significant survivals. Two with breast cancer, with truly 
isolated endobronchial metastasis, had prolonged periods 
of response to hormone therapy, chemotherapy and intra- 
luminal radiotherapy, as described in a small proportion of 
such patients (4). A further patient with disease limited to 
one hemithorax had a successful pneumonectomy (tumour 
crossed the diagonal fissure) and a survival of some 5 yr. If 
detailed investigation, including scanning of thorax, abdo- 
men (including liver), bone and brain shows that the disease 
is truly localized to a single or small number of metastases, 
surgical resection has been shown to be of benefit for such 
localized disease (5,7). Endobronchial metastasis should 
be considered in the differential diagnosis for any patient 
with a previous or concurrent history of extrathoracic 
tumour. Although overall survival is poor, prolonged 
survival with good quality of life is possible in a minority of 
appropriately selected and managed patients. 
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